FdaApplication
BLA 125586
Identifiers
- fda_app_no: BLA125586
Properties
| Property | Value |
|---|---|
| applicant_name | AstraZeneca AB |
| application_type | BLA |
| approval_date | 2018-05-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANDEXXA | — | 100MG | Injection |
| ANDEXXA | — | 200MG | Injection |
2 products